Diabetic nephropathy

被引:0
|
作者
Menne, J. [1 ]
Haller, H. [1 ]
机构
[1] Hannover Med Sch, D-30625 Hannover, Germany
来源
INTERNIST | 2011年 / 52卷 / 05期
关键词
Albuminuria; Hypertension; HbA(1c); Renin angiotensin system; Diabetic nephropathy; STRUCTURAL-FUNCTIONAL RELATIONSHIPS; CARDIOVASCULAR EVENTS; RENAL-DISEASE; MICROALBUMINURIA; INTERVENTION; METAANALYSIS; ALBUMINURIA; PROTEINURIA; PREVENTION; MORTALITY;
D O I
10.1007/s00108-010-2761-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is the most common cause of end-stage renal disease. Since the disease progresses very slowly and usually takes more than 20 years before terminal renal failure occurs, early intervention is of great importance in order to prevent this disabling complication. A good control of diabetes with HbA(1c) levels around 7% is desirable. At least as important is the treatment of elevated blood pressure values. The target value for patients with diabetes has been adjusted in the last year and is now 130-139/80-85 mmHg. Should (micro-)albuminuria or renal insufficiency be present the blood pressure target is < 130/80 mmHg. For the control of hypertension the use of ACE inhibitors or angiotensin receptor blockers is recommended. In addition, the control of other risk factors and appropriate therapeutic intervention is required. A multifactorial intervention leads to the best results and can avoid the occurrence or progression of diabetic kidney disease and other micro- and/or macrovascular complications.
引用
收藏
页码:495 / +
页数:8
相关论文
共 50 条
  • [31] Diabetic nephropathy
    Saemann, A.
    Wolf, G.
    INTERNIST, 2012, 53 (10): : 1195 - 1204
  • [32] Current Update in the Management of Diabetic Nephropathy
    Van Buren, Peter Noel
    Toto, Robert
    CURRENT DIABETES REVIEWS, 2013, 9 (01) : 62 - 77
  • [33] Antihypertensive therapy in patients with diabetic nephropathy
    Mehler, PS
    Schrier, RW
    KIDNEY & BLOOD PRESSURE RESEARCH, 1997, 20 (02) : 74 - 81
  • [34] DIABETIC NEPHROPATHY IN 2014 Improved cardiorenal prognosis in diabetic nephropathy
    Parving, Hans-Henrik
    Rossing, Peter
    NATURE REVIEWS NEPHROLOGY, 2015, 11 (02) : 68 - 69
  • [35] Clinical impact of albuminuria in diabetic nephropathy
    Takashi Wada
    Miho Shimizu
    Tadashi Toyama
    Akinori Hara
    Shuichi Kaneko
    Kengo Furuichi
    Clinical and Experimental Nephrology, 2012, 16 : 96 - 101
  • [36] THE ROLE OF INHIBITORS SGLT2 IN DIABETIC NEPHROPATHY; LITERATURE REVIEW
    Allihybi, Sultan Mohammad
    Alshammari, Rakan Ayyadah
    Alshammari, Basil Ayyadah
    Althobaiti, Khalid Turki
    Almufarriji, Futun Flamed
    Almuqaytib, Ahmed Yousef
    Alrebeh, Doaa Mohammed
    Almadeh, Zahra Mandi
    Alhulw, Fatimah Ali
    Al Abdrabalnabi, Fatimah Ahmed
    PHARMACOPHORE, 2021, 12 (05): : 81 - 84
  • [37] Progression of renal failure in diabetic nephropathy
    Marcantoni, C
    Ortalda, V
    Lupo, A
    Maschio, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 : 16 - 19
  • [38] Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy
    Blouza, Samira
    Dakhli, Sabeur
    Abid, Hafaoua
    Aissaoui, Mohamed
    Ardhaoui, Ilhem
    Ben Abdallah, Nejib
    Ben Brahim, Samir
    Ben Ghorbel, Imed
    Ben Salem, Nabila
    Beji, Soumaya
    Chamakhi, Said
    Derbel, Adnene
    Derouiche, Fethi
    Djait, Faycal
    Doghri, Taieb
    Fourti, Yamina
    Gharbi, Faycel
    Jellouli, Kamel
    Jellazi, Nabil
    Kamoun, Kamel
    Khedher, Adel
    Letaief, Amel
    Limam, Ridha
    Mekaouer, Awatef
    Miledi, Riadh
    Nagati, Khemaies
    Naouar, Meriem
    Sellem, Sami
    Tarzi, Hichem
    Turki, Selma
    Zidi, Borni
    Achour, Abdellatif
    JOURNAL OF NEPHROLOGY, 2010, 23 (04) : 415 - 424
  • [39] Updating the natural history of diabetic nephropathy
    Pugliese, Giuseppe
    ACTA DIABETOLOGICA, 2014, 51 (06) : 905 - 915
  • [40] Non-Proteinuric Diabetic Nephropathy
    Robles, Nicolas Roberto
    Villa, Juan
    Gallego, Roman Hernandez
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (09) : 1761 - 1773